KCAT	Human adenovirus sp.	-999	2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-(1-benzyl-2-oxo-2-thiazol-2-yl-ethyl)-acetamide	*influence of mutant pVIcs on turnover number with (Leu-Arg-Gly-Gly-NH)2-rhodamine as substrate
KCAT	Human adenovirus sp.	-999	more	*influence of mutant pVIcs on turnover number with (Leu-Arg-Gly-Gly-NH)2-rhodamine as substrate
KCAT	Human adenovirus sp.	0.0023	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, in absence of any cofactor
KCAT	Human adenovirus sp.	0.0248	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by viral DNA
KCAT	Human adenovirus sp.	0.271	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by the the 11-amino acid residue peptide from the C-terminus of adenovirus precursor protein and the viral DNA
KCAT	Human adenovirus sp.	2.78	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by viral DNA and the 11-amino acid residue peptide from the C-terminus of adenovirus precursor protein and the viral DNA
KCAT	Human adenovirus sp.	3	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by viral DNA and the 11-amino acid residue peptide from the C-terminus of adenovirus precursor protein and the viral DNA
KM	Human adenovirus sp.	-999	2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-(1-benzyl-2-oxo-2-thiazol-2-yl-ethyl)-acetamide	*influence of mutant pVIcs on Km-value with (Leu-Arg-Gly-Gly-NH)2-rhodamine as substrate
KM	unidentified adenovirus	0.000758	(N-carbobenzyloxy-Nle-Arg-Gly-Gly-NH)2-rhodamine	*
KM	unidentified adenovirus	0.0014	rhodamine 110,bis-(L-leucyl-L-arginylglycylglycine amide),tetrahydrochloride	*
KM	unidentified adenovirus	0.00183	rhodamine 110,bis-(L-leucyl-L-arginylglycylglycine amide),tetrahydrochloride	*
KM	unidentified adenovirus	0.0024	(Nle-Arg-Gly-Gly-NH)2-rhodamine	*
KM	Human adenovirus sp.	0.0034	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by viral DNA and the 11-amino acid residue peptide from the C-terminus of adenovirus precursor protein and the viral DNA
KM	unidentified adenovirus	0.00474	(N-carbobenzyloxy-Met-Arg-Gly-Gly-NH)2-rhodamine	*
KM	unidentified adenovirus	0.005	rhodamine 110,bis-(L-leucyl-L-arginylglycylglycine amide),tetrahydrochloride	*
KM	unidentified adenovirus	0.00517	(Ile-Arg-Gly-Gly-NH)2-rhodamine	*
KM	Human adenovirus sp.	0.0092	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by viral DNA
KM	Human adenovirus sp.	0.0099	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, activation by the the 11-amino acid residue peptide from the C-terminus of adenovirus precursor protein and the viral DNA
KM	Human adenovirus sp.	0.0948	(Leu-Arg-Gly-Gly-NH)2-rhodamine	*pH 8.0, 25&deg;C, in absence of any cofactor
MW	unidentified adenovirus	20000	*	*gel filtration, SDS-PAGE
MW	Human adenovirus sp.	23000	*	*x * 23000, SDS-PAGE
MW	Human adenovirus sp.	23100	*	*x * 23100, calculated from amino acid sequence
MW	unidentified adenovirus	25500	*	*gel filtration, SDS-PAGE
MW	unidentified adenovirus	25500	*	*
SA	unidentified adenovirus	48.9	*	*
